Compositions containing therapeutically active components having enhanced solubility

Details for Australian Patent Application No. 2001273268 (hide)

Owner Allergan, Inc.

Inventors Kerslake, Edward D. S.; Olejnik, Orest

Agent Davies Collison Cave

Pub. Number AU-B-2001273268

PCT Pub. Number WO02/05822

Priority 60218206 14.07.00 US

Filing date 9 July 2001

Wipo publication date 30 January 2002

Acceptance publication date 25 August 2005

International Classifications

A61K 031/557 - Eicosanoids, e.g. leukotrienes

A61K 047/02 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 047/38 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 009/08 Medicinal preparations characterised by special physical form - Solutions

Event Publications

25 August 2005 Application Accepted

  Published as AU-B-2001273268

22 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273269-Compositions containing alpha2-adrenergic agonist components

2001273267